To that end, Amylin is setting up multiple clinical trials to compare the once-weekly Byetta to drugs such as Takeda's Actos and Merck's (NYSE: MRK ) Januvia, as well as to metformin, available as a generic and as Glucophage from Bristol-Myers Squibb (NYSE: BMY ) .